Fintel reports that on April 17, 2023, NEEDHAM & COMPANY INC. maintained coverage of Pharma Mar (XMAD:PHM) with a Buy recommendation.
What is the Fund Sentiment?
There are 58 funds or institutions reporting positions in Pharma Mar. This is an increase of 5 owner(s) or 9.43% in the last quarter. Average portfolio weight of all funds dedicated to PHM is 0.06%, an increase of 0.37%. Total shares owned by institutions increased in the last three months by 12.62% to 1,010K shares.
What are Other Shareholders Doing?
VGTSX - Vanguard Total International Stock Index Fund Investor Shares holds 177K shares representing 0.98% ownership of the company. In it's prior filing, the firm reported owning 178K shares, representing a decrease of 0.11%. The firm decreased its portfolio allocation in PHM by 6.33% over the last quarter.
VTMGX - Vanguard Developed Markets Index Fund Admiral Shares holds 103K shares representing 0.57% ownership of the company. In it's prior filing, the firm reported owning 103K shares, representing a decrease of 0.35%. The firm increased its portfolio allocation in PHM by 9.39% over the last quarter.
IEFA - iShares Core MSCI EAFE ETF holds 82K shares representing 0.45% ownership of the company. No change in the last quarter.
SCZ - iShares MSCI EAFE Small-Cap ETF holds 66K shares representing 0.36% ownership of the company. In it's prior filing, the firm reported owning 64K shares, representing an increase of 2.08%. The firm decreased its portfolio allocation in PHM by 7.29% over the last quarter.
TAISX - TIAA-CREF Quant International Small-Cap Equity Fund Advisor Class holds 59K shares representing 0.32% ownership of the company. In it's prior filing, the firm reported owning 49K shares, representing an increase of 16.24%. The firm increased its portfolio allocation in PHM by 28.43% over the last quarter.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
